GRP
AMRX icon

Global Retirement Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Global Retirement Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$115K Buy
+9,145
New +$105K ﹤0.01% 1824
2024
Q4 		– Sell
-1
Closed -$8 – 3655
2024
Q3 		$8 Hold
1
– – ﹤0.01% 3485
2024
Q2 		$6 Hold
1
– – ﹤0.01% 3533
2024
Q1 		$6 Hold
1
– – ﹤0.01% 3371
2023
Q4 		$5 Buy
+1
New +$4 ﹤0.01% 3343

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Global Retirement Partners's AMRX Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Amneal Pharmaceuticals (AMRX) in Q4 2025: 9,145 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #1824 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AMRX as recently as Q3 2024.

Global Retirement Partners first reported a position in AMRX in Q4 2023 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Global Retirement Partners held 9,145 shares of Amneal Pharmaceuticals worth $115K as of Q4 2025.
  • Amneal Pharmaceuticals was a new Global Retirement Partners position in Q4 2025.
  • Amneal Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1824 holding.
  • Global Retirement Partners first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.